# A Study of the Safety and Efficacy of Anacetrapib (MK-0859) Among Participants With Hypercholesterolemia When Added to Ongoing Statin Therapy (MK-0859-022)

> **NCT01860729** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 589 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Anacetrapib
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01860729
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05-13
- **Primary completion:** 2015-05-29
- **Final completion:** 2015-08-20
- **Target enrollment:** 589 (ACTUAL)
- **Last updated:** 2020-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01860729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01860729, "A Study of the Safety and Efficacy of Anacetrapib (MK-0859) Among Participants With Hypercholesterolemia When Added to Ongoing Statin Therapy (MK-0859-022)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01860729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*